May 2017 Issue of MMM

May 2017 Issue of MMM

Go Figure

4 reasons why patients don't fill their prescriptions

Researchers still don't know why Americans who are prescribed a prescription drug to treat a chronic condition or disease so often fail to fill those ...

Editor's Desk

40 Different Ways to Reshape Healthcare

Healthcare's collision with lower-cost genetic sequencing, mobile tech, AI, and consumerization will transform the trajectory of how we live for the next 10 years.

Digital Edition

Read the complete 2017 Game Changers digital edition

Here you'll find Sara Holoubek's deep dive into how pharma is tackling some of its biggest challenges.

Read the complete May 2017 digital edition

Here you'll find everything from our May 2017 issue, including our Top 40 Transformers, deep dive into autoimmune drugs, and more.

Features

Top 40 Healthcare Transformers of 2017

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts of 2017

For the first time MM&M honors a group of 10 agency execs.

Headliner

J&J's Joaquin Duato: Diversity is 'essential'

Under Duato, the leadership team for Johnson & Johnson's pharma group includes six women. "We don't just talk about it," he says.

Upward Move

Drummy passes the torch at Heartbeat, moves to chairman role

Agency vets Nadine Leonard and James Talerico to co-lead Publicis-owned shop.

Therapeutic Focus

Top 25 autoimmune brands in 2016, based on U.S. sales

AbbVie's Humira tops the list, according to data compiled by EvaluatePharma.

MedImmune goes after challenging lupus market

While investments in investigational lupus agents appear to be heating up, late-stage clinical failure continues to be a major hurdle to market entry.

Drugmakers battle for slice of Humira's billions

Makers of biosimilars have targeted a few of the top-selling autoimmune drugs. Get ready for some of the highest-stakes pricing and access skirmishes in recent ...

In Focus

Some brands thought to shift online ad dollars, creating uncertainty for WebMD

This and other changes in the market have created demand for new offerings, like mobile-friendly sites, video, and patient communities.

Partner Forum

4 Ways for Agencies to Sell Clients on Behavioral Marketing Programs

How can agencies best entice clients to incorporate behavioral science into their marketing programs?

Beltway Insider

Gottlieb Likely to Take On Off-Label, Predictability at the FDA

In short, he'll be further along the learning curve than anyone ever tapped for the nation's number-one public health regulatory slot.

Private View

MSCG's Mark Friedman on Ads with Animals

The chief creative officer takes a look at campaigns in and outside the U.S.

At Work With

Klara's Simon Lorenz on breaking away from the physician lifestyle

He instead decided to find a way to make a physician's job easier by creating a clinical messaging platform.

Back Talk

Who Needs a Gold Watch, Anyway?

Perhaps we should always bear in mind the need to periodically reinvigorate and reshape our careers.

Opinion

How to Shatter the Glass Ceiling

How Pharma Can Benefit from the Transformation of Pharmacy

Newsletters

Live at MM&M Transforming Healthcare

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Value-based care requires innovators to challenge the status quo

Execs stressed the importance of collaboration, consumer-mindedness.

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.